Bluefin Capital Management’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-402,443
Closed -$24.1K 313
2023
Q4
$24.1K Hold
402,443
﹤0.01% 162
2023
Q3
$20.5K Hold
402,443
﹤0.01% 136
2023
Q2
$23.1K Buy
+402,443
New +$24.3K ﹤0.01% 125
2023
Q1
Sell
-436,694
Closed -$39.3K 195
2022
Q4
$56.9K Sell
436,694
-8,220
-2% -$1.03K 0.01% 282
2022
Q3
$53K Sell
444,914
-69,285
-13% -$7.9K ﹤0.01% 376
2022
Q2
$41K Sell
514,199
-15,100
-3% -$2.02K ﹤0.01% 416
2022
Q1
$64K Buy
+529,299
New +$84.5K 0.01% 445

Other funds holding VHAQ.RT

Bluefin Capital Management's VHAQ.RT Position: Q1 2024 in Review

Bluefin Capital Management sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 402,443 shares — an estimated $24.1K sold.

Bluefin Capital Management first reported a position in VHAQ.RT in Q1 2022 and held it in 7 quarters. The position peaked at $64K in Q1 2022. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

  • Bluefin Capital Management reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bluefin Capital Management sold 402,443 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $24.1K.
  • Bluefin Capital Management first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q1 2022 and held it in 7 quarters.
  • Bluefin Capital Management's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $64K in Q1 2022.
  • 5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Bluefin Capital Management's 13F filing for Q1 2024, filed 15 May 2024.